Procédé de détection de snap25 clivé dans des échantillons de tissus
作者： Ron S. Broide , Ester Fernandez-Salas , Brian Cai , Catherine Rheaume , Joseph Francis
DOI:
关键词:
摘要: Cette invention concerne des procedes et compositions permettant de detecter une activite enzymatique BoNT/A dans tissus ou un echantillon tissu. L'invention inclut anticorps qui se lient preferentiellement a SNAP25 clive par est capable intact (non clive),
参考文章(14)
Alexander Grunfeld, Christian A. Murray, Nowell Solish, Botulinum toxin for hyperhidrosis: a review. American Journal of Clinical Dermatology. ,vol. 10, pp. 87- 102 ,(2009) , 10.2165/00128071-200910020-00002
Pamela Ellsworth, Michelle Travis, Onabotulinum toxin A: a therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder. Urologic nursing. ,vol. 34, pp. 165- ,(2014) , 10.7257/1053-816X.2014.34.4.165
Catherine Rhéaume, Brian Cai, Joanne Wang, Ester Fernández-Salas, K. Aoki, Joseph Francis, Ron Broide, A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25 Toxins. ,vol. 7, pp. 2354- 2370 ,(2015) , 10.3390/TOXINS7072354
Koh-ichi Nagata, Ichiro Izawa, Masaki Inagaki, A decade of site- and phosphorylation state-specific antibodies:
recent advances in studies of spatiotemporal protein phosphorylation Genes to Cells. ,vol. 6, pp. 653- 664 ,(2001) , 10.1046/J.1365-2443.2001.00454.X
Patrizia Marini, Roderick A.F MacLeod, Claudia Treuner, Gernot Bruchelt, Waltraud Böhm, Hartwig Wolburg, Paul Schweizer, Rainer Girgert, SiMa, a New Neuroblastoma Cell Line Combining Poor Prognostic Cytogenetic Markers with High Adrenergic Differentiation Cancer Genetics and Cytogenetics. ,vol. 112, pp. 161- 164 ,(1999) , 10.1016/S0165-4608(98)00269-6
Stuart A. Yablon, Mitchell F. Brin, Amanda M. VanDenburgh, Jihao Zhou, Susan M. Garabedian-Ruffalo, Susan Abu-Shakra, Frederick C. Beddingfield, Dose Response with OnabotulinumtoxinA for Post-Stroke Spasticity: A Pooled Data Analysis Movement Disorders. ,vol. 26, pp. 209- 215 ,(2011) , 10.1002/MDS.23426
Birgitte P. S. Jacky, Patton E. Garay, Jérôme Dupuy, Jeremy B. Nelson, Brian Cai, Yanira Molina, Joanne Wang, Lance E. Steward, Ron S. Broide, Joseph Francis, K. Roger Aoki, Raymond C. Stevens, Ester Fernández-Salas, Identification of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Protein Receptor for Botulinum Neurotoxin Serotype A (BoNT/A) PLoS Pathogens. ,vol. 9, pp. e1003369- ,(2013) , 10.1371/JOURNAL.PPAT.1003369
Juan Ramirez-Castaneda, Joseph Jankovic, Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon. ,vol. 90, pp. 344- 348 ,(2014) , 10.1016/J.TOXICON.2014.07.009
K. Roger Aoki, Joseph Francis, Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism & Related Disorders. ,vol. 17, ,(2011) , 10.1016/J.PARKRELDIS.2011.06.013
Ester Fernández-Salas, Joanne Wang, Yanira Molina, Jeremy B. Nelson, Birgitte P. S. Jacky, K. Roger Aoki, Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0049516